Food and Drug Administration (FDA) has now approved two oral GLP-1 drugs: an oral version of Novo Nordisks Wegovy at the end of 2025, and Eli Lillys daily, non-peptide pillorforglipron, a distinct competitor to oral semaglutide and different from Eli Lillys injectable tirzepatidecalled Foundayo in April, which is notable because it can be taken without restrictions on timing or food or water intake
Meal #33: Grilled Chicken Kabobs Ingredients: 5 oz chicken breast, cubed and grilled with vegetables Bell peppers, onions, zucchini on skewers 3/4 cup couscous 1 tablespoon olive oil Why it works: Grilling adds flavor without extra calories
Both promote angiogenesis through different pathways, creating additive effects on blood vessel formation
it included mostly white participants and focused only on people with obesity
L-propionylcarnitine effect on postexercise and postischemic hyperemia in patients affected by peripheral vascular disease